Centre directs states, UTs to conduct sero-surveys for district-level data

The Centre suggested all States/UTs conduct SARS CoV2 serosurveys in consultation with ICMR to generate district-level data.

On Wednesday, the Union Government instructed all states and union territories to undertake SARS CoV2 serological prevalence surveys in collaboration with the Indian Council of Medical Research (ICMR) to provide district-level data.

Union Health Secretary Rajesh Bhushan stated in a letter to additional chief secretaries, principal secretaries, and health secretaries from all states, said that “The findings of such studies can then be utilized quickly by the respective State/UT to guide objective, transparent and evidence-based public health response to COVID-19.”

Bhushan while citing reports of the fourth round of the National Serological prevalence Survey said that “The ICMR has conducted the recent National Serological survey in 70 districts of India. The national serosurvey by ICMR was designed to capture the extent of the spread of COVID infection at the national level. Therefore, the national serosurvey results do not reflect the heterogeneity of seroprevalence between districts and even between states.”

According to the national ICMR survey, approximately 400 million Indians are still vulnerable to COVID-19, with two-thirds of the general population having SARS-CoV-2 antibodies. While most of the Indian population has been exposed to the virus in the previous two months, more than 67.6 per cent had antibodies against the SARS CoV2 virus, which produces COVID-19.

Leave a Reply